Encompass Health Corp (New York Stock Exchange:EHC)
| Market Cap | $13.11B+18.1% |
| Revenue (ttm) | $6.34B+9.4% |
| Net Income | $644.40M+19.1% |
| EPS | $6.40+21.0% |
| Shares Out | 98.12M |
| PE Ratio | 20.63 |
| Forward PE | 19.41 |
| Dividend | $0.78(0.58%) |
| Ex-Dividend Date | Jan 4, 2027 |
| Volume | 911,926 |
| Open | $133.53 |
| Previous Close | $132.28 |
| Day's Range | $132.57 - $134.77 |
| 52-Week Range | $92.77 - $143.90 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | $154.86(+15.87%) |
| Earnings Date | Feb 4, 2027 |
About EHC
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
5 firms rating EHC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Jan 4, 2027Ex-dividend date
- Feb 4, 2027Earnings report
$EHC stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of EHC by members of U.S. Congress
| Lisa C. McClainHouse / R | Sale$1.00K – $15.00K | Oct 31, 2025 |
| Lisa C. McClainHouse / R | Sale$1.00K – $15.00K | Oct 30, 2025 |
| Lisa C. McClainHouse / R | Purchase$1.00K – $15.00K | Oct 30, 2025 |
| Lisa C. McClainHouse / R | Purchase$1.00K – $15.00K | Jul 22, 2025 |
Recently reported changes in EHC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EHC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EHC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EHC Revenue by Segment
| Net operating revenues | $1.61B | 79.05% |
| Adjusted EBITDA | $346.60M | 17.02% |
| Supplies | $65.00M | 3.19% |
| Occupancy costs | $15.00M | 0.74% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EHC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EHC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in EHC
| IJHiShares Core S&P Mid-Cap ETF | $470.25M |
| VTIVanguard Morningstar Total Stock Market ETF | $335.38M |
| VBVanguard Morningstar Small-Cap ETF | $300.60M |
| VBRVanguard Morningstar Small-Cap Value ETF | $195.38M |
| VXFVanguard Extended Market ETF | $151.99M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | $97.70M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from EHC’s recent data — informational, not investment advice
What’s Behind the Score
News check: EHC stock up 34% YTD with analyst coverage questioning if more upside remains, suggesting strong recent performance and continued investor interest.
Recent Insider Activity
Insider Score Trend Over Time
-37.0 since Aug 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| TSCM | TimesSquare Quality Mid Cap Growth ETF | 4.48% |
| BGDV | ETF Series Solutions - Bahl & Gaynor Dividend ETF | 3.41% |
| GLRY | Inspire Growth ETF | 3.30% |
| OSCV | Opus Small Cap Value Plus ETF | 2.78% |
| PJFM | PGIM Jennison Focused Mid-Cap ETF | 2.29% |
| OUSM | ALPS O'Shares U.S. Small-Cap Quality Dividend ETF | 2.22% |
| SCDV | ETF Series Solutions - Bahl & Gaynor Small Cap Dividend ETF | 2.14% |
| YUNG | Corgi ETF Trust I - Longevity Consumer ETF | 2.00% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 1.98% |
| XHS | State Street SPDR S&P Health Care Services ETF | 1.89% |
| DVOL | First Trust Dorsey Wright Momentum & Low Volatility ETF | 1.77% |
| IHF | iShares U.S. Healthcare Providers ETF | 1.69% |
Weight is the stock’s share of each fund’s holdings.
